Global Lactylome Reveals Lactylation-Dependent Mechanisms Underlying CXC Motif Chemokine Ligand 12 Expression in Pulmonary Endothelium During Acute Respiratory Distress Syndrome

Abstract

Acute respiratory distress syndrome (ARDS) is a life-threatening condition affecting millions of people worldwide. The severity of ARDS is associated with the dysfunction of pulmonary endothelial cells (PECs). Metabolic reprogramming is characterized by enhanced glycolysis and lactate accumulation, which play a critical role in this process. Here, we showed that lactate levels in the lungs of patients with ARDS were associated with disease severity and prognosis. Lactate promoted PEC dysfunction and drove experimental ARDS progression via lysine lactylation (Klac), a recently described posttranslational modification. Suppression of lactate-induced lactylation mitigated the development of ARDS and inhibited the release of chemokines, particularly CXC motif chemokine ligand 12 (CXCL12), from PECs. Through quantitative lactylome analysis, we identified hyperlactylation at K193 of Enolase 1 (Eno1), a glycolytic enzyme with RNA-binding capacity, as a previously unknown mechanism promoting CXCL12 production in PECs. Under homeostatic conditions, Eno1 could bind and inhibit the translation of CXCL12 mRNA, whereas increased glycolysis and accumulated lactate drove K193 hyperlactylation of Eno1 to release CXCL12 mRNA for accelerated translation. In addition, K193 hyperlactylation enhanced Eno1 enzymatic activity, further amplifying glycolysis. These findings establish Klac as a link between glycolytic reprogramming and PEC dysfunction, offering a new therapeutic target for ARDS.

Keywords

ARDS / CXCL12 / endothelium / Eno1 / lactylation

References

[1] N. J. Meyer, L. Gattinoni, and C. S. Calfee, “Acute Respiratory Distress Syndrome,” Lancet 398, no. 10300 (2021): 622-637.

[2] M. A. Matthay, Y. Arabi, A. C. Arroliga, et al., “A New Global Definition of Acute Respiratory Distress Syndrome,” American Journal of Respiratory and Critical Care Medicine 209, no. 1 (2024): 37-47.

[3] M. A. Matthay, R. L. Zemans, G. A. Zimmerman, et al., “Acute Respiratory Distress Syndrome,” Nature Reviews Disease Primers 5, no. 1 (2019): 18.

[4] J. D. Crapo, B. E. Barry, P. Gehr, M. Bachofen, and E. R. Weibel, “Cell Number and Cell Characteristics of the Normal Human Lung,” American Review of Respiratory Disease 125, no. 6 (1982): 740-745.

[5] A. Huertas, C. Guignabert, J. A. Barberà, et al., “Pulmonary Vascular Endothelium: The Orchestra Conductor in Respiratory Diseases: Highlights From Basic Research to Therapy,” European Respiratory Journal 51, no. 4 (2018): 1700745.

[6] F. R. Millar, C. Summers, M. J. Griffiths, M. R. Toshner, and A. G. Proudfoot, “The Pulmonary Endothelium in Acute Respiratory Distress Syndrome: Insights and Therapeutic Opportunities,” Thorax 71, no. 5 (2016): 462-473.

[7] G. Eelen, P. de Zeeuw, L. Treps, U. Harjes, B. W. Wong, and P. Carmeliet, “Endothelial Cell Metabolism,” Physiological Reviews 98, no. 1 (2018): 3-58.

[8] X. Li, A. Kumar, and P. Carmeliet, “Metabolic Pathways Fueling the Endothelial Cell Drive,” Annual Review of Physiology 81 (2019): 483-503.

[9] K. Rohlenova, K. Veys, I. Miranda-Santos, K. De Bock, and P. Carmeliet, “Endothelial Cell Metabolism in Health and Disease,” Trends in Cell Biology 28, no. 3 (2018): 224-236.

[10] J. D. Rabinowitz and S. Enerbäck, “Lactate: The Ugly Duckling of Energy Metabolism,” Nature Metabolism 2, no. 7 (2020): 566-571.

[11] X. Li, Y. Yang, B. Zhang, et al., “Lactate Metabolism in Human Health and Disease,” Signal Transduction and Targeted Therapy 7, no. 1 (2022): 305.

[12] K. Yang, M. Fan, X. Wang, et al., “Lactate Induces Vascular Permeability via Disruption of VE-Cadherin in Endothelial Cells During Sepsis,” Science Advances 8, no. 17 (2022): eabm8965.

[13] M. Fan, K. Yang, X. Wang, et al., “Lactate Promotes Endothelial-to-Mesenchymal Transition via Snail1 Lactylation After Myocardial Infarction,” Science Advances 9, no. 5 (2023): eadc9465.

[14] S. Yang, R. Liu, Z. Xin, et al., “Plasma Metabolomics Identifies Key Metabolites and Improves Prediction of Diabetic Retinopathy: Development and Validation Across Multinational Cohorts,” Ophthalmology 131, no. 12 (2024): 1436-1446.

[15] D. Zhang, Z. Tang, H. Huang, et al., “Metabolic Regulation of Gene Expression by Histone Lactylation,” Nature 574, no. 7779 (2019): 575-580.

[16] D. Zhang, J. Gao, Z. Zhu, et al., “Lysine L-Lactylation is the Dominant Lactylation Isomer Induced by Glycolysis,” Nature Chemical Biology 21 (2024): 91-99.

[17] X. Liu, F. Xia, X. Wu, et al., “Isolation of Primary Mouse Pulmonary Microvascular Endothelial Cells and Generation of an Immortalized Cell Line to Obtain Sufficient Extracellular Vesicles,” Frontiers in Immunology 12 (2021): 759176.

[18] A. G. Vassiliou, A. Kotanidou, I. Dimopoulou, and S. E. Orfanos, “Endothelial Damage in Acute Respiratory Distress Syndrome,” International Journal of Molecular Sciences 21, no. 22 (2020): 8793.

[19] A. Bonaventura, A. Vecchié, L. Dagna, et al., “Endothelial Dysfunction and Immunothrombosis as Key Pathogenic Mechanisms in COVID-19,” Nature Reviews Immunology 21, no. 5 (2021): 319-329.

[20] J. S. Pober and W. C. Sessa, “Evolving Functions of Endothelial Cells in Inflammation,” Nature Reviews Immunology 7, no. 10 (2007): 803-815.

[21] J. Wang, Y. Cui, Z. Yu, et al., “Brain Endothelial Cells Maintain Lactate Homeostasis and Control Adult Hippocampal Neurogenesis,” Cell Stem Cell 25, no. 6 (2019): 754-767.e9.

[22] J. Zhang, J. Muri, G. Fitzgerald, et al., “Endothelial Lactate Controls Muscle Regeneration From Ischemia by Inducing M2-Like Macrophage Polarization,” Cell Metabolism 31, no. 6 (2020): 1136-1153.e7.

[23] J. Wu, M. Hu, H. Jiang, et al., “Endothelial Cell-Derived Lactate Triggers Bone Mesenchymal Stem Cell Histone Lactylation to Attenuate Osteoporosis,” Advanced Science 10, no. 31 (2023): e2301300.

[24] O. Culic, M. L. Gruwel, and J. Schrader, “Energy Turnover of Vascular Endothelial Cells,” American Journal of Physiology 273, no. 1 (1997): C205-C213.

[25] A. Krützfeldt, R. Spahr, S. Mertens, B. Siegmund, and H. M. Piper, “Metabolism of Exogenous Substrates by Coronary Endothelial Cells in Culture,” Journal of Molecular and Cellular Cardiology 22, no. 12 (1990): 1393-1404.

[26] K. Irani, “Oxidant Signaling in Vascular Cell Growth, Death, and Survival: A Review of the Roles of Reactive Oxygen Species in Smooth Muscle and Endothelial Cell Mitogenic and Apoptotic Signaling,” Circulation Research 87, no. 3 (2000): 179-183.

[27] S. W. S. Leung and Y. Shi, “The Glycolytic Process in Endothelial Cells and Its Implications,” Acta Pharmacologica Sinica 43, no. 2 (2022): 251-259.

[28] W. Chang, X. Liu, H. Wang, et al., “Lactate Aggravates Inflammation Through the Upregulation of ICAM-1 via GPR81-HSPA12B-Mediated Signaling in Acute Lung Injury,” Chinese Medical Journal 137, no. 15 (2024): 1885-1887.

[29] N. Wang, W. Wang, X. Wang, “Histone Lactylation Boosts Reparative Gene Activation Post-Myocardial Infarction,” Circulation Research 131, no. 11 (2022): 893-908.

[30] Y. Wang, L. Chen, M. Zhang, et al., “Exercise-Induced Endothelial Mecp2 Lactylation Suppresses Atherosclerosis via the Ereg/MAPK Signalling Pathway,” Atherosclerosis 375 (2023): 45-58.

[31] X. Chen, Y. Wang, J. N. Wang, et al., “Lactylation-Driven FTO Targets CDK2 to Aggravate Microvascular Anomalies in Diabetic Retinopathy,” EMBO Molecular Medicine 16, no. 2 (2024): 294-318.

[32] F. Gong, X. Zheng, W. Xu, et al., “H3K14la Drives Endothelial Dysfunction in Sepsis-Induced ARDS by Promoting SLC40A1/Transferrin-Mediated Ferroptosis,” MedComm 6, no. 2 (2025): e70049.

[33] Z. Lu, P. Fang, S. Li, et al., “Lactylation of Histone H3k18 and Egr1 Promotes Endothelial Glycocalyx Degradation in Sepsis-Induced Acute Lung Injury,” Advanced Science 12, no. 7 (2025): e2407064.

[34] L. J. Chen, J. Y. Li, P. Nguyen, et al., “Single-Cell RNA Sequencing Unveils Unique Transcriptomic Signatures of Endothelial Cells and Role of ENO1 in Response to Disturbed Flow,” PNAS 121, no. 5 (2024): e2318904121.

[35] Y. Shi, J. Liu, R. Zhang, et al., “Targeting Endothelial ENO1 (Alpha-Enolase)-PI3K-Akt-mTOR Axis Alleviates Hypoxic Pulmonary Hypertension,” Hypertension 80, no. 5 (2023): 1035-1047.

[36] G. Qiao, A. Wu, X. Chen, Y. Tian, and X. Lin, “Enolase 1, a Moonlighting Protein, as a Potential Target for Cancer Treatment,” International Journal of Biological Sciences 17, no. 14 (2021): 3981-3992.

[37] A. J. Carpousis, “The RNA Degradosome of Escherichia coli: An mRNA-Degrading Machine Assembled on RNase E,” Annual Review of Microbiology 61 (2007): 71-87.

[38] L. Sun, C. Suo, T. Zhang, et al., “ENO1 Promotes Liver Carcinogenesis Through YAP1-Dependent Arachidonic Acid Metabolism,” Nature Chemical Biology 19, no. 12 (2023): 1492-1503.

[39] T. Zhang, L. Sun, Y. Hao, et al., “ENO1 Suppresses Cancer Cell Ferroptosis by Degrading the mRNA of Iron Regulatory Protein 1,” Nature Cancer 3, no. 1 (2022): 75-89.

[40] N. Wang, H. Qiao, J. Hao, et al., “RNA-Binding Protein ENO1 Promotes the Tumor Progression of Gastric Cancer by Binding to and Regulating Gastric Cancer-Related Genes,” Journal of Gastrointestinal Oncology 14, no. 2 (2023): 585-598.

[41] F. Xin and P. Radivojac, “Post-Translational Modifications Induce Significant yet Not Extreme Changes to Protein Structure,” Bioinformatics 28, no. 22 (2012): 2905-2913.

[42] I. Huppertz, J. I. Perez-Perri, P. Mantas, et al., “Riboregulation of Enolase 1 Activity Controls Glycolysis and Embryonic Stem Cell Differentiation,” Molecular Cell 82, no. 14 (2022): 2666-2680.e11.

[43] C. Mayr, “Regulation by 3′-Untranslated Regions,” Annual Review of Genetics 51 (2017): 171-194.

[44] P. Chandrasekaran, N. M. Negretti, A. Sivakumar, et al., “CXCL12 Defines Lung Endothelial Heterogeneity and Promotes Distal Vascular Growth,” Development 149, no. 21 (2022): dev200909.

[45] S. Wang, L. de Fabritus, P. A. Kumar, et al., “Brain Endothelial CXCL12 Attracts Protective Natural Killer Cells During Ischemic Stroke,” Journal of Neuroinflammation 20, no. 1 (2023): 8.

[46] Y. Döring, E. P. C. van der Vorst, J. Duchene, et al., “CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease,” Circulation 139, no. 10 (2019): 1338-1340.

[47] M. J. Delano, K. M. Kelly-Scumpia, T. C. Thayer, et al., “Neutrophil Mobilization From the Bone Marrow During Polymicrobial Sepsis Is Dependent on CXCL12 Signaling,” Journal of Immunology 187, no. 2 (2011): 911-918.

[48] Y. Peng, Q. Wu, H. Tang, et al., “NLRP3 Regulated CXCL12 Expression in Acute Neutrophilic Lung Injury,” Journal of Inflammation Research 13 (2020): 377-386.

[49] J. M. Petty, V. Sueblinvong, C. C. Lenox, et al., “Pulmonary Stromal-Derived Factor-1 Expression and Effect on Neutrophil Recruitment During Acute Lung Injury,” Journal of Immunology 178, no. 12 (2007): 8148-8157.

[50] X. Liu and N. Quan, “Immune Cell Isolation From Mouse Femur Bone Marrow,” Bio-Protocol 5, no. 20 (2015): e1631.

[51] G. Wu, C. Suo, Y. Yang, et al., “MYC Promotes Cancer Progression by Modulating m6 A Modifications to Suppress Target Gene Translation,” Embo Reports 22, no. 3 (2021): e51519.

RIGHTS & PERMISSIONS

2025 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.